Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat

A major challenge in the management of antiretroviral therapy (ART) is to improve the patient’s adherence, reducing the burden caused by the high number of drugs that compose the treatment regimens for human immunodeficiency virus positive (HIV+) patients. Selection of the most appropriate treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Marin, Ruxandra-Cristina, Behl, Tapan, Negrut, Nicoleta, Bungau, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003312/
https://www.ncbi.nlm.nih.gov/pubmed/33803812
http://dx.doi.org/10.3390/biomedicines9030313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003312/
https://www.ncbi.nlm.nih.gov/pubmed/33803812
http://dx.doi.org/10.3390/biomedicines9030313

Ejemplares similares